Lecap Asset Management Ltd. Makes New Investment in Ralliant Corporation $RAL

Lecap Asset Management Ltd. purchased a new stake in Ralliant Corporation (NYSE:RAL) in the 3rd quarter, HoldingsChannel.com reports. The firm purchased 19,304 shares of the company’s stock, valued at approximately $844,000.

Several other hedge funds have also recently modified their holdings of RAL. ORG Partners LLC purchased a new position in shares of Ralliant in the 2nd quarter valued at approximately $70,000. Nordea Investment Management AB purchased a new position in shares of Ralliant in the second quarter worth $29,477,000. Cullen Frost Bankers Inc. acquired a new stake in shares of Ralliant during the second quarter worth $144,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS purchased a new stake in shares of Ralliant during the second quarter valued at $1,410,000. Finally, Boston Partners acquired a new position in shares of Ralliant in the 2nd quarter valued at $63,656,000.

Analyst Upgrades and Downgrades

RAL has been the topic of a number of research reports. Weiss Ratings reissued a “hold (c)” rating on shares of Ralliant in a report on Monday, December 29th. Oppenheimer increased their price target on shares of Ralliant from $55.00 to $60.00 and gave the stock an “outperform” rating in a report on Monday, December 15th. Barclays raised their price target on shares of Ralliant from $59.00 to $60.00 and gave the stock an “overweight” rating in a research report on Wednesday. Royal Bank Of Canada upped their price objective on shares of Ralliant from $45.00 to $52.00 and gave the company a “sector perform” rating in a report on Friday, November 7th. Finally, Citigroup upgraded shares of Ralliant from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $53.00 to $61.00 in a research note on Monday, December 8th. Six analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $58.00.

Ralliant Price Performance

RAL opened at $51.28 on Friday. The company has a fifty day moving average price of $49.15. Ralliant Corporation has a 1 year low of $40.70 and a 1 year high of $55.08. The firm has a market cap of $5.78 billion and a PE ratio of 40.38. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.03 and a current ratio of 1.49.

Ralliant (NYSE:RAL) last released its quarterly earnings data on Wednesday, November 5th. The company reported $0.60 earnings per share for the quarter, beating analysts’ consensus estimates of $0.58 by $0.02. The firm had revenue of $529.10 million during the quarter, compared to analysts’ expectations of $519.14 million. Ralliant has set its Q4 2025 guidance at 0.620-0.680 EPS.

Ralliant Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 23rd. Investors of record on Monday, December 8th were issued a $0.05 dividend. The ex-dividend date of this dividend was Monday, December 8th. This represents a $0.20 dividend on an annualized basis and a yield of 0.4%. Ralliant’s dividend payout ratio is presently 15.75%.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.